Cargando…
Stock price reaction to appointment of a chief health officer during COVID-19
This study examines how appointing a chief health officer (CHO) at the corporate-board level during the COVID-19 outbreak affects the stock returns of US firms. As the COVID-19 progressed, the negative abnormal return (CAR) is −7.5%. In contrast, shares of firms that had appointed a CHO before or du...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259048/ https://www.ncbi.nlm.nih.gov/pubmed/34249615 http://dx.doi.org/10.1016/j.jbef.2021.100541 |